Unknown NA INTERVENTIONAL 1-arm NCT05618132

ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs (ReACHallenge)

Stepwise Treatment and Acetylcholine Rechallenge in Vasospastic Angina to Guide Patient-tailored Treatment

Sponsor: University Hospital, Antwerp

Conditions Angina Pectoris With Normal Coronary Arteriogram Angina Pectoris, Variant Angina Pectoris; Spasm-Induced

Updated 5 times since 2022 Last updated: Jan 17, 2023 Started: Jan 9, 2023 Primary completion: Jan 1, 2024 Completion: Jun 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05618132, this NA trial focuses on Angina Pectoris With Normal Coronary Arteriogram and Angina Pectoris, Variant and remains ongoing. Sponsored by University Hospital, Antwerp, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Nov 2024 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2022 — Feb 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Antwerp

Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Antwerp, Belgium